Thus, current research for Cav-1 in mediating therapeutic resistance of CSCs is limited to a few cancer types, and a more comprehensive approach is needed to validate a critical role of Cav-1 for determining the therapeutic response of CSCs in cancers, and to clarify the physiological function of Cav-1 in maintaining stem cell survival and its molecular network. Here, CAV1 is linked to cancer.